ATE499614T1 - Verfahren zur bestimmung eines gewebeabbauverfahrens durch nachweis von comp- neoepitopen - Google Patents

Verfahren zur bestimmung eines gewebeabbauverfahrens durch nachweis von comp- neoepitopen

Info

Publication number
ATE499614T1
ATE499614T1 AT05748087T AT05748087T ATE499614T1 AT E499614 T1 ATE499614 T1 AT E499614T1 AT 05748087 T AT05748087 T AT 05748087T AT 05748087 T AT05748087 T AT 05748087T AT E499614 T1 ATE499614 T1 AT E499614T1
Authority
AT
Austria
Prior art keywords
comp
neoepitopes
determining
degradation process
tissue degradation
Prior art date
Application number
AT05748087T
Other languages
English (en)
Inventor
Dick Heinegard
Patrik Oennerfjord
Johann Stubendorff
Original Assignee
Anamar Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Anamar Ab filed Critical Anamar Ab
Application granted granted Critical
Publication of ATE499614T1 publication Critical patent/ATE499614T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Apparatus For Radiation Diagnosis (AREA)
AT05748087T 2004-05-24 2005-05-24 Verfahren zur bestimmung eines gewebeabbauverfahrens durch nachweis von comp- neoepitopen ATE499614T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA200400815 2004-05-24
PCT/EP2005/005706 WO2005116658A2 (en) 2004-05-24 2005-05-24 Method for determining a tissue degradation process by detection of comp neoepitopes

Publications (1)

Publication Number Publication Date
ATE499614T1 true ATE499614T1 (de) 2011-03-15

Family

ID=34973791

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05748087T ATE499614T1 (de) 2004-05-24 2005-05-24 Verfahren zur bestimmung eines gewebeabbauverfahrens durch nachweis von comp- neoepitopen

Country Status (6)

Country Link
US (1) US20080318337A1 (de)
EP (1) EP1766411B1 (de)
AT (1) ATE499614T1 (de)
DE (1) DE602005026525D1 (de)
ES (1) ES2360804T3 (de)
WO (1) WO2005116658A2 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2236517A1 (de) * 2009-03-31 2010-10-06 Takara Bio, Inc. Monoklonaler Anti-Fibronektinfragment-Antikörper
WO2011123044A1 (en) * 2010-03-31 2011-10-06 Anamar Ab Method to detect tissue degradation leading to inflammation
WO2014003679A1 (en) 2012-06-28 2014-01-03 Anamar Ab Determining pathological cartilage turnover
SE2430441A1 (en) * 2024-09-03 2026-03-04 SGPTH Life Science AB COMP cleavage peptide and its use in diagnosis of osteoarthritis

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4795702A (en) * 1986-02-05 1989-01-03 Immunogon Associates Diagnostic method for gonorrhea by assay of IgA1 fragments
US5387504A (en) * 1992-09-30 1995-02-07 Merck & Co., Inc. Monospecific antibodies and assay system for detecting stromelysin cleavage products
US5464820A (en) * 1993-06-22 1995-11-07 The University Hospital Specific inhibitors of tissue kallikrein
US7300918B2 (en) * 1994-01-14 2007-11-27 Matthias Rath Method of producing vaccines from protein signal oligopeptides
DE69727582T2 (de) * 1996-08-15 2004-12-23 Novartis Ag Test zur quantifizierung von arthritiszustanden
AU2001250572A1 (en) * 2000-04-07 2001-10-23 Epigenomics Ag Detection of single nucleotide polymorphisms (snp's) and cytosine-methylations

Also Published As

Publication number Publication date
WO2005116658A3 (en) 2006-05-26
DE602005026525D1 (de) 2011-04-07
WO2005116658A2 (en) 2005-12-08
EP1766411A2 (de) 2007-03-28
US20080318337A1 (en) 2008-12-25
ES2360804T3 (es) 2011-06-09
EP1766411B1 (de) 2011-02-23

Similar Documents

Publication Publication Date Title
ATE462000T1 (de) Verfahren zur herstellung von l-arginin, l- ornithin oder l-citrullin
ATE394680T1 (de) Verfahren und vorrichtung zur charakterisierung von analyten
ATE478944T1 (de) Zytokin ligand zur behandlung von asthma und atemwegsüberreaktivität
DK1669463T3 (da) Kaseinhydrolysat, fremgangsmåde til fremstilling af dette og anvendelse af dette
DE602005009856D1 (de) Verfahren zur reinigung von fsh
WO2011010304A3 (en) Method for preparing molecularly imprinted polymers and uses thereof
EP2289544A3 (de) Schutzpeptide gegen S. pneumoniae und diesbezügliche Zusammensetzungen, Verfahren und Verwendungen
WO2006020498A3 (en) Therapeutic agents and methods for cardiovascular disease
DE602005026931D1 (de) Verwendung von vorstufen von enkephalinen und/oder deren fragmenten in der medizinischen diagnostik
ATE547523T1 (de) Vegfr-varianten und deren verwendung bei der diagnose und behandlung von mit schwangerschaft assoziierten medizinischen leiden
DK200601181A (da) Fiskevaccine
ATE534909T1 (de) Verfahren zur proteomischen profilierung mithilfe nichtnatürlicher aminosäuren
DE602006016133D1 (de) Verwendung von stefin a als gerüstprotein
ATE499614T1 (de) Verfahren zur bestimmung eines gewebeabbauverfahrens durch nachweis von comp- neoepitopen
ATE290088T1 (de) Verfahren zur spaltung eines chimeren proteins mittels eines 'processing'-enzyms
DE60028248D1 (de) Methode zur reduzierung der immunogenizität von staphylokinase durch entfernen von t-zell epitopen
WO2007029262A3 (en) Compositions and methods using same for the detection of viruses
WO2004113566A3 (en) Disease related protein network
WO2007013358A3 (en) Vivit polypeptides, therapeutic agent comprising the same, and method of screening for anti-cancer agent
WO2006089801A3 (de) Verfahren zum redox-potential-abhängigen nachweis von targetmolekülen durch wechselwirkende polypeptide
ATE538806T1 (de) Peptide mit spezifischem sitz in herzgefässen und verwandte konjugate und verfahren
WO2003038116A3 (en) Salmonella virulence factors and uses thereof
ATE403873T1 (de) Verfahren zur überwachung der typ-ii- kollagenabbau in knorpeln
Rees The Quagga Mussel (Dreisenna Bugensis) Byssus: A Proteomics Approach to Investigate Underwater Attachment Proteins in a Freshwater Mussel
ATE479745T1 (de) Nukleotidsequenzen codierend für deregulierte phosphoglycerat-dehydrogenasen coryneformer bakterien sowie verfahren zur herstellung von l- serin

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties